With 59% of shoppers seeking tailored nutrition and 70% snacking for comfort, ADM highlights how brands can meet evolving expectations.
Deal expected to close in Q4 2025 pending regulatory approvals
Human trials show rapid, lasting benefits, marking a major step for bio-based ingredients in the nutraceutical sector.
Growth in the Americas and APMEA regions supported Kerry’s first-half performance despite persistent macroeconomic challenges.
The center helps companies scale next-generation foods, like those from precision fermentation, cell cultivation, and plant-based processing, from lab to full production.